Pure Global

Lung Ultrasound in Preterm Infants - Trial NCT05925075

Access comprehensive clinical trial information for NCT05925075 through Pure Global AI's free database. This phase not specified trial is sponsored by Phoenix Children's Hospital and is currently Enrolling by invitation. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05925075
Enrolling by invitation
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT05925075
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Lung Ultrasound in Preterm Infants
Point of Care Lung Ultrasound in Preterm Infants With Respiratory Distress: A Multicenter Prospective Study

Study Focus

Lung Ultrasound

Observational

diagnostic test

Sponsor & Location

Phoenix Children's Hospital

Phoenix, United States of America

Timeline & Enrollment

N/A

Apr 17, 2023

Apr 01, 2025

150 participants

Primary Outcome

Assess predictive ability of lung ultrasound scores in infants at risk of developing bronchopulmonary dysplasia (BPD)

Summary

The goal of this observational study is to learn about the role of bedside lung ultrasound in
 infants born prematurely with breathing problems. The main question this study aims to answer
 is: Can bedside lung ultrasound performed in the first month of life predict the development
 of chronic lung disease in premature infants?

ICD-10 Classifications

Bronchopulmonary dysplasia originating in the perinatal period
Congenital bronchomalacia
Bronchopneumonia, unspecified
Other congenital malformations of bronchus
Diseases of bronchus, not elsewhere classified

Data Source

ClinicalTrials.gov

NCT05925075

Non-Device Trial